Clinical Trials in Austin

Showing 7981-8000 of 11,561 trials

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age

NCT01659086

The purpose of this study is to evaluate the safety, reactogenicity, and immunogenicity of different formulations of a two-dose primary series and booster vaccination of monovalent Influenza H9N2 vaccine manufactured in Quebec, Canada with and without adjuvant, in adults 18 to 64 years of age.

Influenza

GlaxoSmithKline422 participantsStarted Aug 2012

Miami, Florida, United States • Edison, New Jersey, United States • Austin, Texas, United States +1 more locations

TERMINATEDPhase 3< 1 mile

A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

NCT02041091

The purpose of this study is to evaluate the amount of tabalumab in the blood after it is given by two different injection methods - A traditional syringe or a spring loaded syringe for 12 weeks. Participants may continue to receive study drug for up to 52 weeks.

Lupus Erythematosus, Systemic

Eli Lilly and Company226 participantsStarted Jan 2014

Covina, California, United States • El Cajon, California, United States • Long Beach, California, United States +41 more locations

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age

A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

Find Trials by Condition in Austin

A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation

Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus

Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia

Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

Phase III Cat-PAD Study

Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders

Evaluation of the Accuracy of an Implanted Glucose Sensor

A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

Evaluation of Etafilcon A Daily Disposable Lenses

Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older

A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer

Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)

Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear

A Study of Tasisulam in Treating Participants With Malignant Melanoma

Interactive Telehealth for Pressure Ulcer Prevention After SCI

Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma